Literature DB >> 3499123

In vivo studies of articular tissue damage mediated by catabolin/interleukin 1.

J T Dingle1, D P Page Thomas, B King, D R Bard.   

Abstract

A partially purified porcine synovial catabolin interleukin 1 (CF) preparation was injected intra-articularly into rabbit stifle (knee) joints. Radiolabelled CF was rapidly cleared from the joint (0.4 h). Repeated injections of CF caused a marked loss of articular cartilage glycosaminoglycan (GAG) and a great increase in synovial fluid GAG. 35SO4 uptake was inhibited. Time course experiments after a single injection produced similar loss of GAG from knee cartilages, which was maximal three days after injection. The above changes were significantly less with heat inactivated preparations. Loss of articular cartilage metachromasia was found histologically, and an acute synovitis occurred together with lymphocytic foci and plasma cell infiltration.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3499123      PMCID: PMC1002187          DOI: 10.1136/ard.46.7.527

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  15 in total

1.  Intracellular catabolin-like activity in cultured synovial tissue.

Authors:  J T Dingle; E Qi
Journal:  In Vitro       Date:  1983-12

2.  Purification of a factor from human blood monocyte-macrophages which stimulates the production of collagenase and prostaglandin E2 by cells cultured from rheumatoid synovial tissues.

Authors:  J M Dayer; M L Stephenson; E Schmidt; W Karge; S M Krane
Journal:  FEBS Lett       Date:  1981-02-23       Impact factor: 4.124

3.  A new solid-state reagent to iodinate proteins. I. Conditions for the efficient labeling of antiserum.

Authors:  M A Markwell
Journal:  Anal Biochem       Date:  1982-09-15       Impact factor: 3.365

4.  Heberden oration 1978. Recent studies on the control of joint damage: the contribution of the Strangeways Research Laboratory.

Authors:  J T Dingle
Journal:  Ann Rheum Dis       Date:  1979-06       Impact factor: 19.103

5.  Stimulation by human interleukin 1 of cartilage breakdown and production of collagenase and proteoglycanase by human chondrocytes but not by human osteoblasts in vitro.

Authors:  M Gowen; D D Wood; E J Ihrie; J E Meats; R G Russell
Journal:  Biochim Biophys Acta       Date:  1984-02-14

6.  Human mononuclear cell factors mediate cartilage matrix degradation through chondrocyte activation.

Authors:  H E Jasin; J T Dingle
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808

7.  Pig catabolin is a form of interleukin 1. Cartilage and bone resorb, fibroblasts make prostaglandin and collagenase, and thymocyte proliferation is augmented in response to one protein.

Authors:  J Saklatvala; L M Pilsworth; S J Sarsfield; J Gavrilovic; J K Heath
Journal:  Biochem J       Date:  1984-12-01       Impact factor: 3.857

8.  Characterization of proteins from human synovium and mononuclear leucocytes that induce resorption of cartilage proteoglycan in vitro.

Authors:  J Saklatvala; S J Sarsfield; L M Pilsworth
Journal:  Biochem J       Date:  1983-02-01       Impact factor: 3.857

9.  The effect of synovial catabolin on cartilage synthetic activity.

Authors:  J T Dingle
Journal:  Connect Tissue Res       Date:  1984       Impact factor: 3.417

10.  Pig interleukin 1. Purification of two immunologically different leukocyte proteins that cause cartilage resorption, lymphocyte activation, and fever.

Authors:  J Saklatvala; S J Sarsfield; Y Townsend
Journal:  J Exp Med       Date:  1985-10-01       Impact factor: 14.307

View more
  32 in total

1.  Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats.

Authors:  S Cuzzocrea; E Mazzon; C Bevilaqua; G Costantino; D Britti; G Mazzullo; A De Sarro; A P Caputi
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Novel electrospun scaffolds for the molecular analysis of chondrocytes under dynamic compression.

Authors:  Jin Nam; Bjoern Rath; Thomas J Knobloch; John J Lannutti; Sudha Agarwal
Journal:  Tissue Eng Part A       Date:  2009-03       Impact factor: 3.845

3.  Interleukin 13 blocks the release of collagen from bovine nasal cartilage treated with proinflammatory cytokines.

Authors:  C S Cleaver; A D Rowan; T E Cawston
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

4.  Esculetin inhibits cartilage resorption induced by interleukin 1alpha in combination with oncostatin M.

Authors:  S Elliott; A D Rowan; S Carrère; P Koshy; J B Catterall; T E Cawston
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

5.  Effects of murine recombinant interleukin 1 on intact homologous articular cartilage: a quantitative and autoradiographic study.

Authors:  W B van den Berg; F A van de Loo; W A Zwarts; I G Otterness
Journal:  Ann Rheum Dis       Date:  1988-10       Impact factor: 19.103

Review 6.  Role of endothelium in chronic inflammation.

Authors:  M Ziff
Journal:  Springer Semin Immunopathol       Date:  1989

7.  Structural and biochemical abnormalities of articular cartilage in rheumatoid arthritis.

Authors:  D R Mitrovic; N Darmon
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

8.  Protection from interleukin 1 induced destruction of articular cartilage by transforming growth factor beta: studies in anatomically intact cartilage in vitro and in vivo.

Authors:  H M van Beuningen; P M van der Kraan; O J Arntz; W B van den Berg
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

9.  Relationship between radiological knee osteoarthritis and biochemical markers of cartilage and bone degradation (urine CTX-II and NTX-I): the Matsudai Knee Osteoarthritis Survey.

Authors:  Nobuchika Tanishi; Hiroshi Yamagiwa; Tadashi Hayami; Hisashi Mera; Yoshio Koga; Go Omori; Naoto Endo
Journal:  J Bone Miner Metab       Date:  2009-04-21       Impact factor: 2.626

10.  Effects of cyclosporine A on chick osteoclasts in vitro.

Authors:  M H Chowdhury; V Shen; D W Dempster
Journal:  Calcif Tissue Int       Date:  1991-10       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.